High-dosage human albumin infusion may be superior for hypervolemic hyponatremia in cirrhosis with ascites

High-dosage HA should be superior to low-dosage HA for correcting hypervolemic hyponatremia in cirrhosis, especially in those with a baseline ALB level of <30 g/L, probably due to its significant benefit in the improvement of ALB.